Sociocultural Factors - Schizophrenia in African Americans

Key points
- African American families face the challenge of having limited resources.
- Clinical handbook of schizophrenia / edited by Kim T.
- Yet African American families are more likely to retain schizophrenic members in their midst despite limited resources.
- Although the idea that family dynamics "cause" schizophrenia has been discredited, family relationships can certainly affect the course of the illness.
African American families face the challenge of having limited resources. The direct costs of schizophrenia often exceed the median family income of African Americans. Moreover, African Americans are more likely to believe that mentally ill individuals are violent.
Yet African American families are more likely to retain schizophrenic members in their midst despite limited resources. Part of the reason is that African Americans are more tolerant of the often unconventional and unpredictable behavior of a family member with schizophrenia. African Americans are less likely than European Americans to believe that individuals with schizophrenia should be blamed and punished for violent behavior. European American families are more likely to feel burdened and rejecting toward the family member with schizophrenia. Cultural factors may therefore be more important then socioeconomic status in determining whether family members will be caretakers.
Although the idea that family dynamics "cause" schizophrenia has been discredited, family relationships can certainly affect the course of the illness. However, factors that contribute to poor outcome differ in European American and African American families.
High emotionality and family intrusiveness have been shown consistently to predict poor outcome in European Americans with schizophrenia. This does not appear to be the case in African Americans. Critical comments by relatives that were perceived as expressed criticism by European American and Latino family members with schizophrenia were not perceived consistently as criticism by African Americans with schizophrenia. Moreover, in European Americans, family intrusiveness and critical comments, elements considered important in families with high emotionality, showed no association with outcome. Presumably, such behavior was interpreted as displaying more concern in African American families.
The take-home message is that family factors do play an important role in outcomes of African Americans with schizophrenia. African Americans tend to be supportive and to continue family involvement, but they tend to be fearful of the mentally ill. Moreover, the relationships seen in family dynamics and schizophrenia in European Americans may be very different in African Americans. Behavior that is considered toxic in other cultures may be protective in African American cultures. In conclusion, culture is important in family interactions. However, findings about the relationship between schizophrenia and family members in European American families simply may not apply to African Americans and other ethnic minorities.
Treatment Availability
African Americans have more illness burden, because they do not have the same access to services and often receive suboptimal treatment. African Americans are more likely to be homeless or in prison, settings in which treatment is suboptimal. Hospitalization is more common, especially involuntary admissions, and the disposition after discharge is often medication-only or emergency room care. Preferential treatment such as day treatment or case management are less likely to be available.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsDirect Current Stimulation Boosts Cognition in Schizophrenia
Transcranial direct current stimulation (tDCS) may improve short-term memory in people with schizophrenia, a small study suggests. Cognitive impairment is nearly ubiquitous in patients with schizophrenia, and effective…
6 June 2015
NewsInjection Drug Shows Prolonged Effectiveness in Schizophrenia
Monthly injections of paliperidone palmitate showed prolonged efficacy compared with daily oral antipsychotics in a new trial involving a group of schizophrenia patients who rarely participate in clinical research. "A…
4 June 2015
NewsScientists produce strongest evidence yet of schizophrenia's causes
An international team of scientists led by Cardiff University researchers has provided the strongest evidence yet of what causes schizophrenia - a condition that affects around 1% of the global population. Published…




